Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.
Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda JA, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A, Rivero A. Frías M, et al. Among authors: manzanares martin b. Pharmacogenomics J. 2017 Dec;17(6):551-555. doi: 10.1038/tpj.2016.42. Epub 2016 May 31. Pharmacogenomics J. 2017. PMID: 27241060
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.
Rivero-Juarez A, Gonzalez R, Frias M, Manzanares-Martín B, Rodriguez-Cano D, Perez-Camacho I, Gordon A, Cuenca F, Camacho A, Pineda JA, Peña J, Rivero A. Rivero-Juarez A, et al. Among authors: manzanares martin b. Pharmacogenomics J. 2017 Jul;17(4):360-365. doi: 10.1038/tpj.2016.19. Epub 2016 Mar 15. Pharmacogenomics J. 2017. PMID: 26975229
HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.
Frías M, Rodríguez-Cano D, Cuenca-López F, Macías J, Gordon A, Manzanares-Martín B, Pineda JA, Camacho Á, Torre-Cisneros J, Peña J, Rivero-Juárez A, Rivero A. Frías M, et al. Among authors: manzanares martin b. Pharmacogenomics J. 2017 Dec;17(6):479-480. doi: 10.1038/tpj.2016.80. Epub 2016 Oct 25. Pharmacogenomics J. 2017. PMID: 27779247 No abstract available.
KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors.
Morales-Estevez C, De la Haba-Rodriguez J, Manzanares-Martin B, Porras-Quintela I, Rodriguez-Ariza A, Moreno-Vega A, Ortiz-Morales MJ, Gomez-España MA, Cano-Osuna MT, Lopez-Gonzalez J, Chia-Delgado B, Gonzalez-Fernandez R, Aranda-Aguilar E. Morales-Estevez C, et al. Among authors: manzanares martin b. Front Immunol. 2016 Dec 5;7:561. doi: 10.3389/fimmu.2016.00561. eCollection 2016. Front Immunol. 2016. PMID: 27994592 Free PMC article.
Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
Guerrero Puente L, Iglesias Flores E, Benítez JM, Medina Medina R, Salgueiro Rodríguez I, Aguilar Melero P, Cárdenas Aranzana MJ, González Fernández R, Manzanares Martin B, García-Sánchez V. Guerrero Puente L, et al. Among authors: manzanares martin b. Gastroenterol Hepatol. 2017 Nov;40(9):595-604. doi: 10.1016/j.gastrohep.2017.07.005. Epub 2017 Aug 31. Gastroenterol Hepatol. 2017. PMID: 28865888 English, Spanish.
Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis.
Escudero-Contreras A, López-Medina C, Collantes-Estévez E, Ortega-Castro R, Calvo-Gutiérrez J, Mena-Vázquez N, Panero-Lamothe B, Manzanares-Martín B, Cáliz-Cáliz R, Jiménez-Morales A, Ruiz-Jiménez M, Font-Ugalde P. Escudero-Contreras A, et al. Among authors: manzanares martin b. J Clin Med. 2021 Sep 9;10(18):4070. doi: 10.3390/jcm10184070. J Clin Med. 2021. PMID: 34575187 Free PMC article.